Navigation Links
Drug resistance may travel same path as quorum sensing

The cellular "pumps" associated with multi-drug resistance in bacteria may also be involved in exporting signals responsible for cell-cell communication, a process known as quorum sensing, said researchers from Baylor College of Medicine in a report that appears online today in the Proceedings of the National Academy of Sciences.

"We believe that the drugs exported by these pumps may actually be similar in structure to molecules involved in communicating," said Dr. Lynn Zechiedrich, assistant professor of molecular virology and microbiology at BCM. Thus, the drugs get exported by bacterial cells as if they were the usual communication molecules the cells use to transmit information in a bacterial colony.

While giving a patient a drug starts the process, the bacterial cell is "going down some natural pathway of cell-to-cell communication. It's trying to communicate, and when it does, it increases the number of the pumps to try to send out the molecules. The doctor is trying to kill the bacterial cells with drugs, but the cells just make more pumps to communicate better. The effect is that they get rid of the drug," said Zechiedrich.

Instead of bacterial pumps sending out the usual communication signals, they send out drug instead ?inadvertently blocking the ability of the drug to kill the bacteria. This does not occur because the bacteria "know" that the drugs are going to kill them, but because the drug looks like a communication signal. So the bacterial cells send out what they think is a communication signal, which is bad news for doctors and their patients. This process, known as multidrug resistance, results in the failure to cure the bacterial disease. Even worse, the resistance is not just to one drug, but many because the pump is now increased and many different drugs will be pumped out.

"It compounds the problem," said Zechiedrich. Her findings are a step toward understanding the mystery surrounding drug resistance, she said.< /p>

In her work, she found that two of these "pumps" or transporters ?AcrAB/TolC and NorE ?actually export as yet unidentified signals used in cell-to-cell communication.


'"/>

Source:Baylor College of Medicine


Related biology news :

1. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
2. Researchers make gains in understanding antibiotic resistance
3. MUHC scientists describe genetic resistance to rampant virus
4. New polysaccharide may help combat multidrug resistance in cancer
5. New book explains antibiotic resistance for a broad audience
6. Insects develop resistance to engineered crops
7. Retroviral resistance gene found
8. Drug resistance testing in treatment-naive HIV patients is cost-effective
9. Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance
10. Gaining ground in the race against antibiotic resistance
11. Genes linked to treatment resistance in children with leukemia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: